Equities

Invitro International

IVRO:PKC

Invitro International

Actions
  • Price (USD)0.075
  • Today's Change0.00 / 0.00%
  • Shares traded7.58k
  • 1 Year change-25.00%
  • Beta-0.8238
Data delayed at least 15 minutes, as of May 20 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

InVitro International, Inc. is a customer and technology-driven provider of non-animal testing methods. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. The Company produces and sells in vitro assay kits to detect, rank and predict the potential level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). It sells its products direct to customers, independent partner laboratories, and agents in the United States, Europe, Latin America and Asia. It also sells vitro products, which include Ocular Irritection, which is used to evaluate the potential for ocular irritation; Irritection Dermal, which is used to evaluate the potential for dermal irritation and Corrositex, which is used to determine corrosivity level classifications. It also conducts laboratory testing for those customers who prefer not to conduct their own tests.

  • Revenue in USD (TTM)716.89k
  • Net income in USD6.22k
  • Incorporated1985
  • Employees16.00
  • Location
    Invitro International330 E Orangethorpe Ave Ste DPLACENTIA 92870United StatesUSA
  • Phone+1 (949) 851-8356
  • Fax+1 (949) 851-4985
  • Websitehttps://www.invitrointl.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CTT Pharmaceutical Holdings Inc0.00-1.67m1.54m0.00--0.8665-----0.0822-0.08220.000.03460.00-------317.2813.49-448.83304.48------------0.00-------3,454.52------
Bluejay Diagnostics Inc0.00-9.74m1.57m10.00--0.4315-----7.68-7.680.001.250.00----0.00-122.06---149.68--------------0.0048---100.00---7.07------
SOHM Inc-100.00bn-100.00bn1.60m--------------------------------------------------------------
Mallinckrodt PLC1.91bn-1.49bn1.60m2.80k------0.0008-161.65-161.6389.6355.440.40621.574.94681,821.40-31.61-12.49-36.10-15.8526.2235.68-77.83-44.381.63-0.34560.6164---2.53-10.31-83.00------
LadRx Corp0.001.66m1.61m2.000.94374.660.962--3.443.440.000.69730.00----0.0096.28-58.97---78.44------------0.00------106.96------
GRI Bio Inc0.00-12.77m1.62m4.00--0.4912-----26.90-26.900.000.87530.00----0.00-382.23-192.93-869.57-353.99-------37,650.49---16.800.00-------85.61--29.46--
Virpax Pharmaceuticals Inc0.00-16.89m1.63m7.00---------14.42-14.420.00-1.040.00----0.00-156.21-87.52-241.52-116.56--------------------29.84------
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Dermata Therapeutics Inc0.00-8.69m1.67m8.00--6.58-----24.67-24.670.000.57170.00----0.00-120.05---146.08--------------0.00------18.90------
Procyon Corp4.70m-314.48k1.69m17.00--0.7597--0.3597-0.0388-0.03880.58040.29011.401.958.58276,481.20-8.903.52-10.604.2377.6073.30-6.352.522.70--0.00---3.223.1170.44--30.98--
InVitro International716.89k6.22k1.71m16.00214.292.33--2.380.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
PaxMedica Inc0.00-18.15m1.74m6.00--1.40-----11.19-11.190.000.15940.00----0.00-474.77-755.77-781.78-------------3,015.030.00-------23.56------
Link Reservations Inc0.00-480.90k1.85m0.00---------46.51-46.510.00-13.990.00-------246.84-----------------2.43---------22.69------
Qualigen Therapeutics Inc0.00-12.48m1.86m4.00---------2.46-2.640.00-0.39230.00----0.00-118.15---364.72--21.30---------7.41--------10.22------
PainReform Ltd0.00-12.54m1.91m6.00--0.7714-----7.77-7.770.000.99880.00----0.00-158.88-55.47-222.89-68.20------------0.00-------6.28------
Data as of May 20 2024. Currency figures normalised to Invitro International's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.